Moore Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-33,333
| Closed | -$48.3K | – | 530 |
|
|
2024
Q1 | $48.3K | Hold |
33,333
| – | – | ﹤0.01% | 317 |
|
|
2023
Q4 | $3.33K | Hold |
33,333
| – | – | ﹤0.01% | 369 |
|
|
2023
Q3 | $5K | Hold |
33,333
| – | – | ﹤0.01% | 388 |
|
|
2023
Q2 | $3K | Hold |
33,333
| – | – | ﹤0.01% | 447 |
|
|
2023
Q1 | $2K | Hold |
33,333
| – | – | ﹤0.01% | 451 |
|
|
2022
Q4 | $1.52K | Hold |
33,333
| – | – | ﹤0.01% | 506 |
|
|
2022
Q3 | $2K | Hold |
33,333
| – | – | ﹤0.01% | 647 |
|
|
2022
Q2 | $5K | Hold |
33,333
| – | – | ﹤0.01% | 659 |
|
|
2022
Q1 | $10K | Hold |
33,333
| – | – | ﹤0.01% | 714 |
|
|
2021
Q4 | $17K | Hold |
33,333
| – | – | ﹤0.01% | 710 |
|
|
2021
Q3 | $18K | Hold |
33,333
| – | – | ﹤0.01% | 763 |
|
|
2021
Q2 | $34K | Buy |
+33,333
| New | +$34K | ﹤0.01% | 775 |
|